文献速递头颈部肿瘤放疗放疗物理与技术

头颈癌IMRT全唾液腺保护对患者报告口干及头颈生活质量的影响

Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.
PubMed 文献 · Radiother Oncol · 2017-08-16

本研究纳入252例接受双侧颈部全唾液腺保护IMRT的头颈癌患者,纵向分析约600份问卷,评估问卷评分与双侧腮腺、对侧颌下腺及口腔平均剂量的关系。多因素分析显示双侧腮腺和口腔剂量与口干及进食相关评分显著相关,对侧颌下腺剂量与头颈生活质量总分相关;147例对侧颌下腺平均剂量≤39Gy者无对侧IB区失败。

要点

  • 降低全部唾液腺剂量可最大化改善患者报告结局。
  • 双侧腮腺和口腔剂量与口干及进食评分显著相关。
  • 对侧颌下腺平均剂量≤39Gy未增加对侧IB区失败风险。

核心结论

  • 降低所有唾液腺剂量可最大化改善患者报告的口干及头颈生活质量。
  • 对侧颌下腺剂量约束≤39Gy不增加对侧IB区失败风险。

研究设计与样本

  • 纵向研究,252例接受双侧颈部全唾液腺保护IMRT的头颈癌患者完成约600份问卷。
  • 采用纵向回归分析问卷评分与双侧腮腺、对侧颌下腺及口腔平均剂量的关系。
  • 使用边际R2和AIC进行模型评价。

主要发现

  • 单因素分析中,双侧腮腺、对侧颌下腺和口腔剂量与XQ-summary、XQ-eating和HNQOL-eating评分显著相关。
  • 多因素分析中,双侧腮腺和口腔剂量与XQ-summary、XQ-eating和HNQOL-eating评分显著相关。
  • 多因素分析中,对侧颌下腺剂量与HNQOL-summary显著相关。
  • 联合三个结构剂量对XQ-summary、XQ-rest、XQ-eating和HNQOL-eating的R2最高。
  • 147例对侧颌下腺平均剂量≤39Gy的患者中,对侧IB区无失败。

关键数值与推荐

  • 对侧颌下腺平均剂量约束≤39Gy。
  • 双侧腮腺、对侧颌下腺和口腔剂量联合时模型R2最高。

临床怎么用

  • 头颈癌IMRT计划设计时应尽可能降低双侧腮腺、对侧颌下腺和口腔剂量以改善患者报告结局。
  • 可考虑将对侧颌下腺平均剂量约束在≤39Gy,不增加对侧IB区失败风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: While parotid-sparing intensity modulated radiotherapy (IMRT) has demonstrated superiority to conventional RT in terms of observer-rated xerostomia, patient-reported outcome measures (PROMs) have only marginally improved. We investigated how sparing all salivary glands affects PROMs. MATERIALS AND METHODS: Patients treated to the bilateral neck with all-gland-sparing IMRT answered xerostomia (XQ) and head-and-neck quality of life (HNQOL) questionnaires. Longitudinal regression was used to assess the relationship between questionnaire scores and mean bilateral parotid gland (bPG), contralateral submandibular gland (cSMG), and oral cavity (OC) doses. Marginal R2 and Akaike information criterion (AIC) were used for model evaluation. RESULTS: 252 patients completed approximately 600 questionnaires. On univariate analysis, bPG, cSMG, and OC doses significantly correlated with XQ-summary, XQ-eating, and HNQOL-eating scores. On multivariate analysis, bPG and OC doses significantly correlated with XQ-summary, XQ-eating, and HNQOL-eating scores; and cSMG dose with HNQOL-summary. Combining doses to all three structures yielded the highest R2 for XQ-summary, XQ-rest, XQ-eating, and HNQOL-eating. In the 147 patients who received a mean cSMG dose ≤39Gy, there were no failures in contralateral level IB. CONCLUSIONS: Reducing doses to all salivary glands maximizes PROMs. A cSMG dose constraint of ≤39Gy does not increase failure risk.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Hawkins PG, Lee JY, Mao Y, et al. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life. Radiother Oncol. 2017. PMID: 28823405. doi:10.1016/j.radonc.2017.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。